Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tuneable one-step PEG-silane functionalisation strategy for controlled DNA probe immobilisation and enhanced hybridisation on silicon photonic biosensors.

Talanta·2026

Same author

Bridging classical and neural methods for improved segmentation in mathematical text based images.

Scientific reports·2025

Same author

A hyphenated approach of chemical profiling, anti-bacterial assays, and molecular docking to validate the traditionally claimed anti-bacterial (Krimiroga) potential of Cyperus rotundus L.

Microbial pathogenesis·2025

Same author

Author's reply: "Methodological and interpretational concerns in pancreatic cyst biomarker study".

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025

Same author

<i>Elwendia persica</i> (Boiss.) Pimenov & Kljuykov from Indian Western Himalaya: impact of geographical locations on essential oil yield, chemical diversity, anti-bacterial, anti-diabetic and anti-oxidant activities.

Natural product research·2025

Same author

Long-term validation of intra-cystic biomarkers for pancreatic cysts.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

KRAS assay selection: sensitivity and accuracy in clinical application.

Marta Herreros-Villanueva¹, Gaurav Aggarwal

¹Research Unit, Hospital General Yagüe, Avenida del Cid 96, 09005 Burgos, Spain. martahvh1978@hotmail.com

Molecular Biology Reports

|June 10, 2011

Summary

KRAS mutation testing is crucial for EGFR-targeted therapies, but commercial assays vary. Further studies are needed to compare assay performance and establish a gold standard for accurate KRAS mutational status determination.

More Related Videos

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents

Published on: August 16, 2024

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

Related Experiment Videos

Last Updated: Jun 1, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents

Published on: August 16, 2024

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

Area of Science:

Oncology
Molecular Diagnostics
Pharmacogenomics

Background:

KRAS mutation status is a key biomarker for predicting response to epidermal growth factor receptor (EGFR) inhibitors like cetuximab and panitumumab.
Accurate KRAS testing is essential for guiding treatment decisions in patients with cancers, particularly colorectal cancer.

Purpose of the Study:

To highlight the need for comparative studies on the operational characteristics of commercially available KRAS mutation detection assays.
To emphasize the importance of understanding assay variability in specificity, sensitivity, and precision for clinical decision-making.

Main Methods:

This study is a review and analysis of existing literature and commercial assay information.
It focuses on the implications of assay differences rather than novel experimental methods.

Main Results:

Currently, there is a lack of published data directly comparing the performance metrics of various in vitro diagnostic KRAS assays.
Differences in assay characteristics may lead to variations in reported KRAS mutation status, potentially impacting treatment selection.

Conclusions:

Physicians must be aware of the limitations of available KRAS testing methods when interpreting results.
Further research is required to establish a gold standard assay for reliable KRAS mutation detection to ensure optimal patient care.